enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Dreading a colonoscopy? There are alternatives | Savvy Senior

   www.aol.com/dreading-colonoscopy-alternatives...

   Cologuard, which is covered by most private insurers and Medicare, detects 92% of colon cancers but only 42% of large precancerous polyps. It also may provide a false-positive, indicating that you ...

3. New colorectal cancer blood test approved by FDA: What to know

   www.aol.com/colorectal-cancer-blood-test...

   The Food and Drug Administration (FDA) has recently approved a blood test screening for colorectal cancer that has an over 83% success rate at detecting the presence of this form of cancer.

4. FDA approves new blood test to screen for colon cancer

   www.aol.com/news/fda-approves-blood-test-screen...

   This is the second blood test to screen for colon cancer; Epigenomics’ Epi proColon was approved in 2016. But it’s rarely used, Smith said, because of concerns about its accuracy. It's also ...

5. FDA Clears Exact Sciences' Next-Generation Colorectal Cancer ...

   www.aol.com/fda-clears-exact-sciences-next...

   The Cologuard test is a first-line colorectal cancer screening test for adults age 45 or older at average risk for the disease. Upon launch in 2025, the Cologuard Plus test will be supported by ...

6. Guardant's blood-based cancer test moves closer to Medicare ...

   www.aol.com/news/us-fda-approves-guardant-health...

   Exact Sciences' stool test Cologuard had a 92.3% sensitivity rate. Colorectal cancer occurs in about 150,000 patients in the U.S. annually and is the second-leading cause of cancer fatalities in ...

7. Exact Sciences Corp. - Wikipedia

   en.wikipedia.org/wiki/Exact_Sciences_Corp.

   Exact Sciences Corp. is an American molecular diagnostics company based in Madison, Wisconsin specializing in the detection of early stage cancers. The company's initial focus was on the early detection and prevention of colorectal cancer; in 2014 it launched Cologuard, the first stool DNA test for colorectal cancer.

8. Fecal immunochemical test - Wikipedia

   en.wikipedia.org/wiki/Fecal_immunochemical_test

   The fecal immunochemical test (FIT) is a diagnostic technique that examines stool samples for traces of non-visible blood, which could potentially indicate conditions including bowel cancer. [1] Symptoms which could be caused by bowel cancer and suggest a FIT include a change in bowel habit, anaemia , unexplained weight loss, and abdominal pain .

9. Stool test - Wikipedia

   en.wikipedia.org/wiki/Stool_test

   A multi-target stool DNA test was approved in August 2014 by the FDA as a screening test for non-symptomatic, average-risk adults 50 years or older. [8] A 2017 study found this testing to be less cost effective compared to colonoscopy or fecal occult blood testing. [9]